[ad_1]
The World Health Organization leads this agreement, known as “Kovacs”, to ensure the participation of the research, purchase and distribution of any new vaccine equally between the richest countries of the world and the developing world, and to make in the face of the growing threat of so-called “vaccine nationalism”. The Alliance for Innovations in Epidemic Preparedness and the Global Alliance also participate in it. Vaccinations and immunizations, according to The Guardian.
According to the newspaper, 35 countries from the rich country have joined, in addition to the European Commission, which will buy doses on behalf of the 27 member states of the European Union in addition to Norway and Iceland, and another 38 countries are expected to join in the future.
Ultimately, the agreement aims to provide two billion doses of safe and effective vaccines worldwide by the end of 2021, as governments, vaccine manufacturers, organizations and individuals have allocated $ 1.4 billion. for vaccine research and development to date.
The United States and China were absent from the agreement, and Washington announced that it prefers to sign bilateral agreements, in addition to focusing on distributing the epidemic vaccine to its own population, while China confirmed that it continues to consult with the World Health Organization.
The agreement provides for the provision of vaccines approved in principle to 3% of the population of participating countries, increasing over time to 20% of the most vulnerable population in each country.
He states that at this point in the epidemic, it would be a plausible scenario that while supplies of Corona vaccines are still extremely scarce, countries should initially focus on reducing deaths and protecting the health system.
“This, for example, will allow front-line workers in health and social care settings in most countries to be vaccinated, and then others as more supplies become available,” the agreement added.
Tedros Adhanom Ghebreyesus, head of the United Nations Health Authority, revealed the agreement at a press conference in Geneva on Monday, that Kovacs represents the largest and most diverse portfolio of Corona vaccines in the world, as priority is given to the who are most at risk.
He said: “This is a mechanism that enables global coordination of the propagation process to achieve the greatest possible impact. It will help control the epidemic and ensure that the race for vaccines is a cooperation, not a competition.”
He added that the program would guarantee vaccinations for some people in all countries, not for all people in some countries.
“Governments on all continents have chosen to work together, not only to secure vaccines for their populations, but also to help ensure that vaccines are available to the most vulnerable everywhere,” said Dr. Seth Berkeley, Director. GAVI Alliance Executive.
He continued: “With the commitments we announced today to the Kovacs Foundation, in addition to the historic partnership we have established with the industry, we now have a much better chance of ending the acute phase of this epidemic as soon as safe and effective vaccines are available. “.
While Dr. Richard Hatchett, Executive Director of the Alliance for Epidemic Preparedness Innovations, emphasized that this is a watershed moment in the history of public health, as the international community comes together to face this pandemic.
